Document is current
Any future updates will be listed below
-
Authors
Wang, Xinyue
Li, Zhaona
Wang, Liuchun
Liang, Yan
Huang, Chun
Chen, Peng
Huang, Dingzhi
Song, Xia
Ding, Cuimin
Wang, Changli
Jiang, Richeng
-
Funding
Funding for this research was provided by:
National Natural Science Foundation of China (82172620, 82172620, 82172635, 82172635, 82172620)
Tianjin Key Medical Discipline (Specialty) Construction Project (TJYXZDXK-010A, TJYXZDXK-010A, TJYXZDXK-010A, TJYXZDXK-010A, TJYXZDXK-010A, TJYXZDXK-010A, TJYXZDXK-010A, TJYXZDXK-010A, TJYXZDXK-010A)
- License Information
-
More Information
Article History
Received: 26 September 2024
Accepted: 31 March 2025
First Online: 15 April 2025
Declarations
:
: This study was first approved by the ethics committee of the Tianjin Medical University Cancer Institute & Hospital, and the approval number was E2019157. The trial was conducted in accordance with the Declaration of Helsinki (2010), Good Clinical Practice and Chinese regulations on clinical trial research and was approved by the institutional review boards or independent ethics committees of the participating study centers. Written informed consent was obtained from all participants.
: Not applicable.
: The authors declare no competing interests.
